Latest Class Actions News

DUG Technology has resolved a US$2.1 million legal dispute with a supplier by agreeing to a US$1.5 million settlement, avoiding further court action without admitting liability.

Collins Foods has agreed to settle a class action over employee 10-minute rest breaks for up to AUD 9 million, pending Federal Court approval. The settlement includes flexible terms based on participant numbers, with no admission of liability.

Keybridge Capital has obtained Italian court orders freezing AUD 4.7 million in assets tied to a waterfront property, as part of ongoing legal efforts to recover funds transferred in 2024.

Structural Monitoring Systems PLC reported a 31% revenue increase to AUD 16.5 million for H1 2025, driven by strong avionics growth and improved profitability despite ongoing litigation and leadership changes.

Shine Justice Ltd has reported a strong turnaround in its half-year results to December 2025, posting an 8% revenue increase and a return to profitability with a $6.7 million net profit. The legal services firm saw robust growth in personal injury litigation and ongoing class actions, despite cash flow challenges from delayed settlements.

Coles Group reported a 2.5% revenue increase to $23.7 billion for the half year ended January 2026, driven by strong supermarket sales, but earnings were weighed down by a $235 million provision linked to a Fair Work Ombudsman ruling. The company declared a fully franked interim dividend of 41 cents per share.

Dubber Corporation reported a 9% revenue decline to $18.7 million for the half-year ending December 2025, alongside a 65% reduction in net loss. The company pursues growth through AI innovation and cost efficiencies while navigating ongoing legal proceedings.

Lendlease Group reported a significant $318 million statutory loss for the half year ended December 2025, driven by impairments and lower transaction earnings. The company plans a $3 billion capital recycling program to reduce gearing and strengthen its balance sheet.

Novatti Group has been served a writ in Malaysia over disputed earn-out payments from its 2022 ATX acquisition, with a claim of approximately AUD 2.67 million. Despite the legal challenge, ATX’s financial performance remains on an upward trajectory.

Telix Pharmaceuticals delivered a strong 56% revenue increase in 2025, driven by U.S. sales of Illuccix and the launch of Gozellix, while advancing its therapeutic pipeline and expanding global manufacturing capabilities. Despite a net loss, the company is investing heavily in R&D and sustainability initiatives aligned with climate-related disclosures.

Mayne Pharma has initiated legal proceedings against Cosette Pharmaceuticals and associated parties, seeking substantial damages following the collapse of their acquisition deal.

BHP Group Limited reported a robust half-year to December 2025, with copper overtaking iron ore as the top earnings contributor and a detailed technical assessment released for its promising Vicuña copper-gold project.